Essential resources, easily available.

Our e-learning modules, resources and forums provide oncology pharmacy staff with the tools required to stay abreast of the latest developments to improve patient care.

eLearning

  • Field-specific online modules
  • Supporting certification that can be used to support CPD
  • Keep up to date within the field of oncology pharmacy
  • Stop and continue the course at a time that suits you
Explore eLearning

Your community

  • Innovation through collaboration
  • Communicate with other members of the oncology pharmacy network
  • Share documents and links
  • Submit posts quickly and easily on our interactive forums
Explore community

Resources

  • Access to BOPA publications and position statements
  • Links for further reading and information
  • Checked and verified documents ensures material is current
  • Quick downloads
Explore resources

Latest news

By BOPA Research Committee on 25th April 2024

Survey: Pharmacogenomic Panel Testing in Cancer: UK Oncology Professionals

Please consider completing our BOPA member survey on the use of pharmacogenomic panel testing in people with solid tumours. Survey information I’m a pharmacist and pre-doctoral research fellow researching the…

Read article
By BOPA Research committee on 25th April 2024

NIHR Associate Principal Investigator (PI) Scheme is continuing to host Research Learning Lectures

The NIHR Associate Principal Investigator (PI) Scheme is continuing to host the Research Learning Lectures; a series of lectures for anyone in Health and Social Care interested in learning more about research.…

Read article
By BOPA on 16th April 2024

Abstract Submission for #BOPA2024 is NOW OPEN

Abstract Submission for the 27th Annual BOPA Conference in 2024 is now OPEN   Delegates are invited to present results of their clinical and technical work as a poster with…

Read article
By BOPA Research Subcommittee on 15th April 2024

Survey: Service Evaluation on Carboplatin Variation in UK

We invite members to complete this service evaluation to understand national variations in carboplatin dosing for adult patients receiving SACTs. We are looking at whether we can standardise carboplatin protocols…

Read article
Further news